54868-5385 Anagrelide - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

54868-5385

Brand Name:

Anagrelide

Generic Name:

Anagrelide

Dosage Form Name:

Capsule

Administration Route:

Oral

Substances:

Packages:

Code: 54868-5385-00

Description:

Effective Date: Aug. 15, 2005

Discontinued: June 30, 2011

Code: 54868-5385-01

Description:

Effective Date: Aug. 15, 2005

Discontinued: June 30, 2011

SEER*Rx Category:

Ancillary Therapy

Major Class:

Platelet-Reducing Agent

Minor Class:

PDE-3 Inhibitor

Orphan Drug Designation:

Status:

No Longer Used